GLP-1s
Bodd Lands $15M for Body-Scanning Tech, With an Eye Toward GLP-1 Users
Bodd has raised $15 million to expand its body-scanning tech into the U.S. and U.K. while preparing pharmacy deployments for GLP-1 users.
Fitness Stakeholders Urge Strength Training for GLP-1 Users
Les Mills and ukactive are urging the healthcare and fitness sectors to promote strength training and adequate protein intake for people taking weight-loss drugs.
Beyond Botox: Med-Spas Find Their Next Chapter in Longevity
Med-spas are evolving into longevity clinics as GLP-1 users and wellness consumers seek regenerative treatments.
GLP-1s Could Reduce US Deaths by 9% in Best Case Scenario, Report Finds
Anti-obesity medications like GLP-1s have the potential to significantly reduce mortality in countries across the globe, per a new report.
HFA Backs Trump’s GLP-1 Medicare Expansion, Urges Exercise Coverage
The Health & Fitness Association has praised the expansion of Medicare to cover GLP-1 drugs and calls for the coverage of exercise programs.
GLP-1 Use Doubles Across America — Here’s Who’s Taking Them
New Gallup data shows GLP-1 use has doubled nationwide as telehealth startups and investors are reshaping the weight-loss market.
WeightWatchers, Amazon Team Up for Fast-Tracked Weight-Loss Meds
WeightWatchers has teamed with Amazon Pharmacy to simplify access to GLP-1 weight-loss drugs with real-time stock updates and home delivery.
Personal Trainers Say Their Jobs Are Changing Due to the Rise of GLP-1s
NASM's new survey of 500 fitness pros shows GLP-1 drugs like Ozempic are reshaping the industry and the role of personal trainers.
Pvolve Does Strength Smarter To Keep You Fit Longer
Functional fitness brand Pvolve is contributing to the increased strength training demand, longevity movement and GLP-1 boom all at once
Wearables Uncover Hidden Insights Into Overeating in New Study
A necklace, wristband and bodycam helped researchers reveal five hidden overeating styles that could shape the future of obesity treatment.
